Retirement of Non-Executive Chair
0
Patrys has today announced that the Company’s long-standing Chair, Mr John Read, will be retiring as the Non-Executive Chair, and…
Quarterly Activities Report & 4C – 30 June 2022
Patrys has today released its Quarterly Activities Report and Appendix 4C Quarterly Cash Flow report for the quarter ended 30…
PAT-DX1 Engineering Run Successfully Completed
Patrys has today announced a positive update on the second engineering run for its lead asset PAT-DX1, a critical step…
Patrys Investor Newsletter
Our latest Investor Newsletter is here. This edition includes an update from Patrys CEO and MD, Dr James Campbell; a…
Patrys on Channel 7 News
Channel 7 News Journalist Jackie Quist recently interviewed Patrys CEO and MD, Dr James Campbell, together with Telethon Kids Institute’s,…
PAT-DX1 Significantly Improves Survival in Animal Model of Pancreatic Cancer
Patrys has today announced the publication of new data from a series of studies by our collaborators Dr James Hansen,…
Cure Brain Cancer Foundation Research Grant
Patrys is pleased to share news that the Telethon Kids Institute has been awarded significant funding from the Cure Brain…
Mergermarket | Interview with Dr James Campbell
Patrys CEO and MD, Dr James Campbell, was recently interviewed by Louise Weihart at Mergermarket, to discuss the deal potential…
ABC NEWS | May 2022
Patrys CEO and Managing Director, Dr James Campbell, is presenting at the 16th Bioshares Biotech Summit to be hosted in…
Quarterly Activities Report and 4C
Patrys has published its Quarterly Activities Report and 4C Quarterly Cash Flow Report. Highlights for this Quarter have included: Work…